Skip to main content

Table 3 Results for the FAS after 6 and 12 months (mRS, mortality)

From: The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial

 

Placebo

Dexamethasone

Total

p-value

N = 19

N = 19

N = 38

Dichotomized mRS at 6 months

 < = 2

12 (63.2%)

12 (63.2%)

24 (63.2%)

1.0000

 > 2

7 (36.8%)

7 (36.8%)

14 (36.8%)

 

Mortality at 6 months

 Alive

18 (100%)

14 (93.3%)

32 (97.0%)

0.2660

 Dead

0 (0)%)

1 (6.7%)

1 (3.1%)

 

 Missing

1

4

5

 

Dichotomized mRS at 12 months

 < = 2

9 (56.3%)

7 (53,8%)

16 (55.2%)

0.8970

 > 2

7 (43.8%)

6 (46.2%)

13 (44.8%)

 

 Missing

3

6

9

 

Mortality at 12 months

 Alive

13 (86.7%)

11 (91.7%)

24 (88.9%)

0.6812

 Dead

2 (13.3%)

1 (8.3%)

3 (11.1%)

 

 Missing

4

7

11